MLANA Antikörper (C-Term)
Kurzübersicht für MLANA Antikörper (C-Term) (ABIN4911789)
Target
Alle MLANA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 60-92, C-Term
-
Verwendungszweck
- MART-1/Melan-A (6C4) Monoclonal Antibody
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.
-
Immunogen
- This MART-1/Melan-A antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 60-92 amino acids from the C-terminal region of human MART-1/Melan-A.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB(1:300-5000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin, Sodium azide
-
Vorsichtsmaßnahmen
- This product contains ProClin and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- MLANA (Melan A (MLANA))
-
Andere Bezeichnung
- MART-1/Melan-A
-
Hintergrund
-
Synonyms: MART1, MART-1, Melanoma antigen recognized by T-cells 1, Antigen LB39-AA, Antigen SK29-AA, Protein Melan-A, MLANA
Background: Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.
-
Gen-ID
- 2315
-
UniProt
- Q16655
Target
-